Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMUP-IA-01 in Knee Osteoarthritis
NCT04037345Phase 1Completed
- Sponsor
- MEDIPOST
- Start
- Oct 2019
- Primary completion
- Nov 2020
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
Phase 1, open-label trial of SMUP-IA-01 in osteoarthritis (OA) (3 arms), sponsored by MEDIPOST. Primary endpoint: Change of total score in WOMAC (Western Ontario and McMaster University Osteoarthritis Index) at 6 months. Started Oct 2019; status: completed.
02
Drugs
SMUP-IA-01
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04037345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04037345.